<?xml version="1.0" encoding="UTF-8"?>
<p class="p">FAS has been proposed as a potential therapeutic target for the treatment of obesity (
 <xref rid="B54" ref-type="bibr" class="xref">54</xref>, 
 <xref rid="B57" ref-type="bibr" class="xref">57</xref>), and grape skin extract and resveratrol have shown FAS enzyme-inhibiting properties. In 3T3-L1 pre-adipocytes, resveratrol reduced lipid accumulation (
 <xref rid="B58" ref-type="bibr" class="xref">58</xref>). Furthermore, resveratrol treatment decreased the epididymal adipose tissue 
 <italic class="italic">Fasn</italic> mRNA expression in high fat diet-fed mice (
 <xref rid="B59" ref-type="bibr" class="xref">59</xref>). FAS inhibition is followed by malonyl-CoA, acetyl-CoA and NADPH accumulation, which is interpreted by the cell as a signal for abundance of energy (
 <xref rid="B58" ref-type="bibr" class="xref">58</xref>).
</p>
